|Tender Details : |
Object of the contract
Description: Contract notice: Pharmaceutical products
Authority Type: Body governed by public law
Contact Nature: Supplies
Procedure: Open procedure
Document: Contract notice
Regulation: European Union
Award criteria: Lowest price
CPV code: 33600000,33600000,33600000
CPV Description: - - 130a para. 8 SGB V allows the health insurance companies (KK) and pharmaceutical companies to carry out frame-rate agreements on the costs of the sale of medicinal products (Travoprost, Etoricoxib) Of the statutory KK. The GWQ will be used as a company for profitabilityD Quality at KK acc. - 130a para. 8 p. 5 SGB V for their shareholder and customer funds. In view of the statutory provisions governing the award of public contracts, a regular process of active substance-related, public procurement procedure is carried out by GWQ ServicePlus AG in accordance with the regulations of Part Four of the GWB. Until the coming into effect of new medicineElrabattvertraege would like the GWQ with all interested pharmaceutical companies, drug discounts in the context of the open house procedure to the active substances in the u. a. Losenabschliessen. The earliest start of the contract is 1.09.2017.
GWQ ServicePlus AG intends to grant non-exclusive discount agreements pursuant to section 130a para. 8 SGB V to the above- Active substance with contract start as of 1 Jan.7. GWQ assumes that this procedure is not within the scope of application of the cartel awarding authority because of the lack of a selection decision and the non-discriminatory accessibility of all pharmaceutical companiesRight. The contract documents, the participating health insurance funds and their transpositions, as well as the dates for the notification of the contract, can be viewed and downloaded on the GWQServicePlus AG procurement portal at http://vergabeportal.gwq-serviceplus.de. Until the start-up contract is concluded, this transition agreement shall be open to all market participantsThe following documents are to be submitted: - a signed contract in duplicate, - a proof of the authorization under the law of medicine by means of an excerpt from the public part of the AMIS database;
- Signed self-declaration (Annex 3).
1. It's a NacTo obtain authorization from the AMIS database by means of an extract from the public part of the AMIS database. A signed declaration (Appendix 3) must be submitted as proof of the reliability and declaration that the statutory provisions on the minimum wage and the tariff rebate are respected.
GWQ acts on behalf of the following statutory health insurance funds:
Betriebskrankenkasse of MTU Friedrichshafen GmbH
Betriebskrankenkasse Herford Minden Ravensberg
BKK Akzo Nobel Bavaria
BKK German Bank AG
BKK Faber-Castelldex * Leuze
THE BERGISCHE KRANKENKASSE
Schwenninger health insurance
home health insurance
HEK Hanseatische Krankenkasse
IKK Brandenburg and Berlin
IKK gesund plus
SBK Siemens company health insurance
SECURVITA BKK BKK SKD
Suedzucker BKK BKK Wieland
Note: The first award in this process, before 10 calendar days naCh The publication of this EU notice is published in the Official Journal.
The contract documents may also be sent by e-mail to the address given under I.1. Mentioned contact point. The tender documents will then be sent by e-mail. Questions and notes on the tender documents are available by e-mail or in writing (mFax or letter) to the persons referred to in I.1. Contact point. They are to be formulated in German. Responses are made available in an anonymous form to all companies which have requested the submission of subcontracting documents (http://vergabeportal.gwq-serviceplus.de/arzneimittel)
Internet address (URL): http://www.gwq-serviceplus.de
Directive: Classical Directive (2014/24/EU)